Skin Cancer

Skin cancer is the most common type of cancer in the U.S. It occurs in more than a million people each year, including many older people. There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Of the three, melanoma is the most serious. Skin cancer occurs when abnormal cells form and multiply in an uncontrolled way in the epidermis, or abnormal cells from the epidermis invade the dermis of the skin. Basal cell carcinoma, squamous cell carcinoma, and melanoma are skin cancers that are named for the epidermal cells from which they develop.
What is Skin Cancer?

Skin cancer is the most common type of cancer among light skinned individuals. It is the commonest cancer in the United States and in Australia. Each year, about one million people are diagnosed with this cancer. In 85 percent of these cases, the skin damage leading to the cancer occurs before an individual is 18.

Read More

Overview

Feature Articles

Latest Skin Cancer News and Research

Moffitt researchers find immune-oncologic differences in prostate tumors of African American men

Moffitt researchers find immune-oncologic differences in prostate tumors of African American men

Study findings may help identify new targets to inhibit spread of melanoma

Study findings may help identify new targets to inhibit spread of melanoma

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Novel findings on mole growth could pave way for skin cancer treatments

Novel findings on mole growth could pave way for skin cancer treatments

Ludwig study uncovers a nutritional approach to improve cancer immunotherapy

Ludwig study uncovers a nutritional approach to improve cancer immunotherapy

UCLA researchers receive $13 million NIH grant to combat melanoma

UCLA researchers receive $13 million NIH grant to combat melanoma

Study shows effectiveness of UV-C light for killing COVID-19 on N95 respirators

Study shows effectiveness of UV-C light for killing COVID-19 on N95 respirators

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

Hannover and Rostock team up to develop non-invasive optical melanoma diagnostics

Researcher describes a new approach to study the process of wound healing

Researcher describes a new approach to study the process of wound healing

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Cell signaling research rings warning bells over an emerging cancer drug target

Cell signaling research rings warning bells over an emerging cancer drug target

DNA damage may occur far away from the point of incidence of radiation

DNA damage may occur far away from the point of incidence of radiation

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Nanotechnological drug delivery system enhances the effectiveness of melanoma treatment

Study shows how mutations in DNA packaging machines can drive cancer development

Study shows how mutations in DNA packaging machines can drive cancer development

Scientists identify key driver in BRAF inhibitor resistant melanoma

Scientists identify key driver in BRAF inhibitor resistant melanoma

Antihypertensive drugs are not linked to cancer, shows study

Antihypertensive drugs are not linked to cancer, shows study

Research reveals how quickly pre-cancerous skin lesions can form on the DNA

Research reveals how quickly pre-cancerous skin lesions can form on the DNA

Genes on the X chromosome may be key to melanoma survival advantage in females

Genes on the X chromosome may be key to melanoma survival advantage in females